Supplemental material
Journal of Medical Economics
Volume 27, 2024 - Issue 1
Open access
507
Views
0
CrossRef citations to date
0
Altmetric
Infectious Diseases
Cost-effectiveness and impact on infections and associated antimicrobial resistance of 20-valent pneumococcal conjugate vaccine in US children previously immunized with PCV13
Mark H. Rozenbauma Pfizer Inc., Collegeville, PA, USACorrespondence[email protected]
, Liping Huanga Pfizer Inc., Collegeville, PA, USA
, Alejandro Canea Pfizer Inc., Collegeville, PA, USA
, Adriano Arguedasa Pfizer Inc., Collegeville, PA, USA
, Ruth Chapmanb Evidera, London, UK
, Desmond Dillon-Murphyb Evidera, London, UK
, Maria J. Torta Pfizer Inc., Collegeville, PA, USA
, Vincenza Snowa Pfizer Inc., Collegeville, PA, USA
, Erica Chilsona Pfizer Inc., Collegeville, PA, USA
& Raymond Farkouha Pfizer Inc., Collegeville, PA, USA
show all
Pages 644-652
|
Received 16 Feb 2024, Accepted 03 Apr 2024, Published online: 19 Apr 2024
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.